These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 14734504)

  • 1. Endothelial dysfunction in pulmonary hypertension.
    Budhiraja R; Tuder RM; Hassoun PM
    Circulation; 2004 Jan; 109(2):159-65. PubMed ID: 14734504
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic abnormalities of the endothelium.
    Butany JW; Verma S; Leask RL; Mohsen B; Asa SL
    Microsc Res Tech; 2003 Jan; 60(1):30-7. PubMed ID: 12500258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current view on pathophysiology of pulmonary arterial hypertension].
    Cisowska M; Lewczuk J
    Pol Merkur Lekarski; 2007 Apr; 22(130):286-90. PubMed ID: 17684928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in autoimmune rheumatic diseases.
    Carreira PE
    Autoimmun Rev; 2004 Jun; 3(4):313-20. PubMed ID: 15246028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of pulmonary vascular tone during exercise in health and pulmonary hypertension.
    Merkus D; de Beer VJ; Houweling B; Duncker DJ
    Pharmacol Ther; 2008 Sep; 119(3):242-63. PubMed ID: 18586325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights on the pathogenesis of pulmonary arterial hypertension.
    Perros F; Dorfmüller P; Humbert M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in infancy and childhood.
    Mathew R; Gewitz MH
    Heart Dis; 2000; 2(5):362-8. PubMed ID: 11728283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasoregulating activity of the endothelium and pulmonary hypertension].
    Karoli NA; Rebrov AP
    Ter Arkh; 2004; 76(12):39-44. PubMed ID: 15724924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension and sepsis: prothrombotic profile and inflammation can changes pulmonary mechanics?
    Tauil KM; Gaio E; Melo-Silva CA; Carvalho RS; Amado VM
    Med Hypotheses; 2014 Sep; 83(3):290-1. PubMed ID: 24957506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].
    Duong-Quy S; Rivière S; Bei Y; Duong-Ngo C; Le-Dong NN; Hua-Huy T; Dinh-Xuan AT
    Rev Mal Respir; 2012 Oct; 29(8):956-70. PubMed ID: 23101638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
    Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
    Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects.
    Yang Z; Kaye DM
    Trends Cardiovasc Med; 2006 May; 16(4):118-24. PubMed ID: 16713534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
    Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
    Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide is a regulator of pulmonary vascular tone. A hypothesis.
    Westendorp RG; Roos AN; Meinders AE
    Neth J Med; 1990 Dec; 37(5-6):167-70. PubMed ID: 2150094
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiologic basis for the treatment of pulmonary hypertension.
    Olschewski H; Olschewski A; Rose F; Schermuly R; Schütte H; Weissmann N; Seeger W; Grimminger F
    J Lab Clin Med; 2001 Nov; 138(5):287-97. PubMed ID: 11709653
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of the pulmonary circulation.
    Barer G
    Physiol Bohemoslov; 1989; 38(1):1-12. PubMed ID: 2524074
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular endothelium summary statement V: Pulmonary hypertension and acute lung injury: public health implications.
    Hooper WC; Mensah GA; Haworth SG; Black SM; Garcia JG; Langleben D
    Vascul Pharmacol; 2007 May; 46(5):327-9. PubMed ID: 17197249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to reverse the endothelial dysfunction in pulmonary arterial hypertension?
    Barst R
    J Am Coll Cardiol; 2007 Apr; 49(14):1572-4. PubMed ID: 17418298
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
    Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.